Ulrika Yngve
Researcher at Department of Medicinal Chemistry; Preparative Medicinal Chemistry
- Telephone:
- +46 18 471 41 24
- E-mail:
- ulrika.yngve@scilifelab.uu.se
- Visiting address:
- Uppsala Biomedicinska Centrum, BMC, Husarg. 3
- Postal address:
- Box 574
751 23 UPPSALA
- CV:
- Download CV
Short presentation
Head of Facility, Medicinal Chemistry, Lead Identification, Drug Discovery and Development Platform, Science for Life Laboratory. Information about the platform can be found at https://www.scilifelab.se/platforms/ddd.

Publications
Selection of publications
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Part of Neuropharmacology, p. 293-300, 2017
Part of MedChemComm, p. 422-431, 2013
Part of Chemistry and Biodiversity, p. 2442-2452, 2012
Recent publications
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Part of Journal of labelled compounds & radiopharmaceuticals, p. 1106-1109, 2018
Part of Neuropharmacology, p. 293-300, 2017
Tracing BACE: Synthesis and evaluation of beta-secretase inhibitors as ligands for PET imaging
Part of Journal of labelled compounds & radiopharmaceuticals, 2015
All publications
Articles in journal
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Part of Journal of labelled compounds & radiopharmaceuticals, p. 1106-1109, 2018
Part of Neuropharmacology, p. 293-300, 2017
Tracing BACE: Synthesis and evaluation of beta-secretase inhibitors as ligands for PET imaging
Part of Journal of labelled compounds & radiopharmaceuticals, 2015
Part of MedChemComm, p. 422-431, 2013
Part of Chemistry and Biodiversity, p. 2442-2452, 2012
Part of Journal of Medicinal Chemistry, p. 6866-6880, 2012
Part of Nuclear Medicine and Biology, p. 1073-1078, 2004
Microwave accelerated 68Ga-labelling of oligonucleotides
Part of Journal of Labelled Compounds & Radiopharmaceuticals, p. 79-89, 2004
Labelling of octreotide using Br-76-prosthetic groups
Part of Journal of labelled compounds & radiopharmaceuticals, p. 561-573, 2001
Part of European Journal of Pharmaceutical Sciences, p. 179-186, 2000
Part of Nuclear Medicine and Biology, p. 851-853, 2000
Part of Acta Chemica Scandinavica, p. 508-512, 1999
Part of Acta Chemica Scandinavica, p. 651-669, 1999
Conference papers
Tritium labeling of a class of spirooxazaindolamines possessing analgesic properties.
Part of Synth. Appl. Isot. Labelled Compd., Proc. Int. Symp., 8th, p. 285-288, 2004
Part of Synth. Appl. Isot. Labelled Compd. 1997, Proc. Int. Symp., 6th, p. 303-305, 1998
Patents
2014
2014
2014
2011
Preparation of imidazolyl-pyrimidine derivatives as GSK3 inhibitors.
2008
Preparation of arylimidazopyridine derivatives for use as GSK3 modulators.
2008
Preparation of imidazopyridinecarboxamide derivatives for use as GSK3 modulators.
2008
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
2006
Preparation of five-membered heterocyclic compounds as mGluR5 receptor antagonists.
2004